Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Characterization of a novel antibacterial agent that inhibits bacterial translation.

Böddeker N, Bahador G, Gibbs C, Mabery E, Wolf J, Xu L, Watson J.

RNA. 2002 Sep;8(9):1120-8.

2.

Inhibition by thiopeptin of bacterial protein synthesis.

Liou YF, Kinoshita T, Tanaka N.

Jpn J Microbiol. 1976 Jun;20(3):233-40.

3.

Ribosomal alterations contribute to bacterial resistance against the dipeptide antibiotic TAN 1057.

Limburg E, Gahlmann R, Kroll HP, Beyer D.

Antimicrob Agents Chemother. 2004 Feb;48(2):619-22.

4.

Cis-acting resistance peptides reveal dual ribosome inhibitory action of the macrolide josamycin.

Lovmar M, Vimberg V, Lukk E, Nilsson K, Tenson T, Ehrenberg M.

Biochimie. 2009 Aug;91(8):989-95. doi: 10.1016/j.biochi.2009.05.002.

PMID:
19463886
5.

Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell-free systems derived from both gram-positive and gram-negative bacteria.

McNicholas PM, Najarian DJ, Mann PA, Hesk D, Hare RS, Shaw KJ, Black TA.

Antimicrob Agents Chemother. 2000 May;44(5):1121-6.

6.

Oxazolidinone antibiotics target the P site on Escherichia coli ribosomes.

Aoki H, Ke L, Poppe SM, Poel TJ, Weaver EA, Gadwood RC, Thomas RC, Shinabarger DL, Ganoza MC.

Antimicrob Agents Chemother. 2002 Apr;46(4):1080-5.

7.
8.

Oxazolidinones mechanism of action: inhibition of the first peptide bond formation.

Patel U, Yan YP, Hobbs FW Jr, Kaczmarczyk J, Slee AM, Pompliano DL, Kurilla MG, Bobkova EV.

J Biol Chem. 2001 Oct 5;276(40):37199-205.

9.

Inhibition of protein synthesis by streptogramins and related antibiotics.

Cocito C, Di Giambattista M, Nyssen E, Vannuffel P.

J Antimicrob Chemother. 1997 May;39 Suppl A:7-13. Review.

10.
11.

Some properties and the possible role of intrinsic ATPase of rat liver 80S ribosomes in peptide bond elongation.

Ogata K, Ohno R, Terao K, Iwasaki K, Endo Y.

J Biochem. 2000 Feb;127(2):221-31.

12.

Assays for the identification of inhibitors targeting specific translational steps.

Brandi L, Dresios J, Gualerzi CO.

Methods Mol Med. 2008;142:87-105. doi: 10.1007/978-1-59745-246-5_8.

PMID:
18437308
13.
14.
15.

Specific, efficient, and selective inhibition of prokaryotic translation initiation by a novel peptide antibiotic.

Brandi L, Fabbretti A, La Teana A, Abbondi M, Losi D, Donadio S, Gualerzi CO.

Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):39-44.

16.

Characterization of a high-throughput screening assay for inhibitors of elongation factor p and ribosomal peptidyl transferase activity.

Swaney S, McCroskey M, Shinabarger D, Wang Z, Turner BA, Parker CN.

J Biomol Screen. 2006 Oct;11(7):736-42.

PMID:
16928980
17.

Novel tetrapeptide inhibitors of bacterial protein synthesis produced by a Streptomyces sp.

Brandi L, Lazzarini A, Cavaletti L, Abbondi M, Corti E, Ciciliato I, Gastaldo L, Marazzi A, Feroggio M, Fabbretti A, Maio A, Colombo L, Donadio S, Marinelli F, Losi D, Gualerzi CO, Selva E.

Biochemistry. 2006 Mar 21;45(11):3692-702.

PMID:
16533052
19.

Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis.

Llano-Sotelo B, Dunkle J, Klepacki D, Zhang W, Fernandes P, Cate JH, Mankin AS.

Antimicrob Agents Chemother. 2010 Dec;54(12):4961-70. doi: 10.1128/AAC.00860-10.

20.

Conservation of bacterial protein synthesis machinery: initiation and elongation in Mycobacterium smegmatis.

Bruell CM, Eichholz C, Kubarenko A, Post V, Katunin VI, Hobbie SN, Rodnina MV, Böttger EC.

Biochemistry. 2008 Aug 26;47(34):8828-39. doi: 10.1021/bi800527k.

PMID:
18672904
Items per page

Supplemental Content

Support Center